A new generation of weight-loss drugs is getting closer to patients. Here's how they differ from Wegovy and Zepbound.
Eli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA.
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
BTC
ETH
BNB
ADA
XRP
DOGE
SOL
DOT
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesEli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA.
Austria's top court rules Meta's ad model illegal, orders overhaul of user data practices in EU
Tilray and Canopy Growth shares are among big gainers Thursday.
Athira Pharma stock soars after acquiring rights to Phase 3 breast cancer drug
Abivax stock rises after announcing acceptance of 22 abstracts at ECCO 2026
You've probably never heard of RRP Semiconductor Ltd., but you're certainly going to wish you had invested in it two years ago
Integer stock rises after activist investor reportedly builds stake and urges sale
Can Micron blowout memory outlook turn around AI sentiment?
Curiously, those events which have shaken markets most severely in recent years are low down the list of priorities for 2026 in investor mindsets.
Birkenstock sees muted sales growth and profit as tariffs hurt margins
Trump Media bets on fusion energy with $6 billion TAE deal
Micron's dramatic beat has analysts feeling upbeat about the company's ability to be a huge beneficiary of the AI boom.